CRMs Enhance Tumor Reduction During Chemotherapy

D

Dr. Guido Kroemer on Rhonda Patrick's podcast.

General HealthMedical

Quotes From Source

“Removing T-cells abolishes tumor reduction by CRMs and chemotherapy.”

Story of claim

Combining caloric restriction mimetics (CRMs) like hydroxycitric and spermidine with chemotherapy can enhance tumor reduction by boosting the immune response. This approach could be promising for cancer patients.

  • Goal: Enhance tumor reduction during chemotherapy.
  • Proof: CRMs boost anti-cancer immune response, enhancing chemotherapy's effectiveness, as claimed by Dr. Kroemer.
  • Nuances:
    • CRMs include hydroxycitric and spermidine supplements.
    • Testing CRM efficacy with immunotherapies could be promising.
  • Impact on Life: Potential for improved cancer treatment outcomes and increased long-term survival for patients.

Investments

  • Price: Estimated $50-100 per month for supplements
  • Time: Supplementation during chemotherapy cycles
  • Effort: Requires monitoring and coordination with healthcare providers

Risks

Potential interactions with chemotherapy drugs. Consultation with a healthcare provider is essential.

Alternatives

  • Exploring immunotherapy options as standalone treatments
  • Traditional chemotherapy without supplements

Get Started 🚀

  • Consult with your oncologist about using CRMs.
  • Purchase hydroxycitric and spermidine supplements.
  • Begin supplementation as advised by your healthcare provider.
  • Monitor immune markers and tumor response regularly.

Brogevity AI can make mistakes. Check important info.

Reference Video